United Research Labs

Filtering by:

We lost the trail.

Sorry, we didn't find any items in United Research Labs

Related Products
Carlson Labs Niacin Time 500 mg  250 Tablets Carlson Labs Niacin Time is a time released Niacin supplement. Carlson Labs ...
Description:
Carlson Labs Niacin Time 500 mg  250 Tablets Carlson Labs Niacin Time is a time released Niacin supplement. Carlson Labs Niacin Time is an essential B Vitamin (B 3). Carlson Labs Niacin Time is involved in the normal metabolism of ...
Carlson Labs Niacin Time 500 mg  500 Tablets Carlson Labs Niacin Time is a time released Niacin supplement. Carlson Labs Niacin ...
Description:
Carlson Labs Niacin Time 500 mg  500 Tablets Carlson Labs Niacin Time is a time released Niacin supplement. Carlson Labs Niacin Time is an essential B Vitamin (B 3). Carlson Labs Niacin Time is involved in the normal metabolism of fats ...
Mycology Research Labs Cordyceps MRL 90 TabletsMycology Research Labs Cordyceps MRL (Grifola frondosa) is not an extract of Grifola frondosa, ...
Description:
Mycology Research Labs Cordyceps MRL 90 TabletsMycology Research Labs Cordyceps MRL (Grifola frondosa) is not an extract of Grifola frondosa, the powder does contain's both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a ...

More About United Research Labs

With more than 60 years of experience as a generic pharmaceutical Research & Development (R&D) and manufacturing company, URL Pharma has successfully transitioned into a growing research and technology-driven, proprietary-branded pharmaceutical business. Our growth in 2009 was driven primarily by our branded/licensing products.

Our strategy is to develop and commercialize scientifically and medically innovative products and technologies that fulfill unmet medical needs. These advances are protected by intellectual property or regulatory exclusivity.
 
Branded innovations.
URL Pharma successfully commercialized its first internally developed branded product, Qualaquin®, in 2006; and in 2009 introduced COLCRYS® and FIBRICOR®. Our substantial discovery pipeline includes products in mid-to-late-stage development expected to launch over the next 5 years, available for out-licensing and useful for near term life cycle management.
 
URL Pharma is committed to addressing safety issues facing the pharmaceutical industry.
Our primary scientific focus is to enhance the safety and efficacy profiles of medicines through clinical study and formulation development.